Remove Bioethics Remove COVID-19 Remove Licensing Remove Public Health
article thumbnail

When Crafting Public Health Policy, the Perfect Shouldn’t Be the Enemy of the Good

Bill of Health

For example, public health officials at virtually every level have resisted implementation or reinstatement of mask mandates in part by arguing that either some percentage of the population will not mask or that mask mandates alone will be ineffective. Sound familiar? It’s one justification for pandemic policy inaction in a nutshell.

article thumbnail

Reasonable Pricing Clauses: A First Step Toward Ensuring Taxpayers a Fair Return on their Public R&D Investment

Bill of Health

By Nikhil Chaudhry and Reshma Ramachandran Earlier this month, the Department of Health and Human Services announced that it had successfully included a reasonable pricing provision in a $326M investment contract with Regeneron for development of a next generation monoclonal antibody therapy for COVID-19. pharmaceutical market.

COVID-19 205
article thumbnail

The 2021 Shkreli Awards: Lown Institute Counts Down the Top 10 Healthcare Industry Abuses in the Coronavirus Pandemic

Health Populi

When he led Turing Pharmaceuticals in 2015, he acquired a license for the drug Daraprim (an anti-malarial therapy also used for HIV/AIDS), raising the drug price from $13.50 health care system. 8 – These towns trusted a doctor to set up COVID testing; sample patient fee = #1,944. #7 a pill to $750 a pill. government. . #8